| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.879 | 3.997 | 5.528 | 2.996 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.879 | 3.997 | 5.528 | 2.996 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 8.306 | 8.983 | 10.388 | 11.409 | 2.147 | 1.391 | 3.294 | 903 | 0 | 1.368 |
| Gross Profit/Loss - EUR | -4.427 | -4.986 | -4.860 | -8.413 | -2.147 | -1.391 | -3.294 | -903 | 0 | -1.368 |
| Net Profit/Loss - EUR | -4.543 | -5.065 | -4.915 | -8.443 | -2.147 | -1.391 | -3.294 | -903 | 0 | -1.368 |
| Employees | 2 | 2 | 2 | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
Check the financial reports for the company - Body-Nycol - Impex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.110 | 9.160 | 10.275 | 5.243 | 5.203 | 5.138 | 5.367 | 5.297 | 5.281 | 5.893 |
| Inventories | 9.780 | 9.079 | 10.101 | 5.135 | 5.036 | 4.941 | 4.815 | 4.830 | 4.816 | 4.789 |
| Receivables | 95 | 35 | 17 | 78 | 137 | 130 | 407 | 409 | 407 | 405 |
| Cash | 235 | 47 | 157 | 30 | 30 | 68 | 144 | 58 | 58 | 700 |
| Shareholders Funds | -15.170 | -20.080 | -24.656 | -32.646 | -34.161 | -34.904 | -37.424 | -38.443 | -38.326 | -39.481 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 25.280 | 29.240 | 34.930 | 37.889 | 39.364 | 40.042 | 42.791 | 43.740 | 43.607 | 45.374 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5211 - 5211" | |||||||||
| CAEN Financial Year |
4719
|
|||||||||
Comments - Body-Nycol - Impex S.r.l.